⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SPTX News
Seaport Therapeutics, Inc. Common Stock
Seaport Therapeutics to Present at Citi’s 2026 Biopharma Back to School Conference and Participate in 21 st Annual Wells Fargo Healthcare Conference
businesswire.com
SPTX
Form 8-K
sec.gov
SPTX
Seaport Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
businesswire.com
SPTX
PureTech Founded Entity Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo™ in Healthy Volunteers
businesswire.com
SPTX
Form 8-K
sec.gov
SPTX
Seaport Therapeutics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
businesswire.com
SPTX
Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo™ in Healthy Volunteers
businesswire.com
SPTX
Form 8-K
sec.gov
SPTX
Seaport Therapeutics Announces Pricing of Upsized Initial Public Offering
businesswire.com
SPTX